Sökning: "Natriuretic peptide"

Visar resultat 1 - 5 av 83 avhandlingar innehållade orden Natriuretic peptide.

  1. 1. The endocrine heart - metabolic actions of atrial natriuretic peptide

    Författare :Amra Jujic; Kardiovaskulär forskning - hypertoni; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Atrial natriuretic peptide; type 2 diabetes; rs5068; insulin resistance; glucose dependent insulinotropic peptide; glucagon-like peptide-1; left ventricular hypertrophy;

    Sammanfattning : Abstract The natriuretic peptides (NPs), namely atrial natriuretic peptide (ANP) and bran natriuretic peptide (BNP), which are secreted from cardiomyocytes in response to cardiac wall stress, play a significant role in the regulation of blood pressure, intravascular volume, and cardiac remodeling. Recently, NPs emerged as hormones with metabolic actions such as inhibition of the renin-angiotensin system and inhibition of inflammation, together with lipolysis and adipose tissue browning. LÄS MER

  2. 2. Nitrates and Left Ventricular Dysfunction

    Författare :Erik Tingberg; Kardiologi; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; lipid peroxidation; malondialdehyde; peptide; brain natriuretic peptide; left ventricular dysfunction; nitrates; acute myocardial infarction; heart failure; atrial natriuretic; diuretics; echocardiography; haemodynamic measurements; neurohumoral activation; diastolic dysfunction; Cardiovascular system; Medicin människa och djur ; Medicine human and vertebrates ; Kardiovaskulära systemet; oxidative stress; isoprostanes;

    Sammanfattning : Use of beta-blockers and inhibitors of the renin angiotensin system (RAS) is established practice in the treatment of chronic heart failure (CHF). Clinical studies also suggest beneficial long-term effects of nitrates in CHF. LÄS MER

  3. 3. Preeclampsia – Studies on the Placenta and B-type Natriuretic Peptide

    Författare :Katja Junus; Matts Olovsson; Anna-Karin Wikström; Stefan Hansson; Liv Cecilie Vestrheim Thomsen; Uppsala universitet; []
    Nyckelord :MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; BNP; B-type natriuretic peptide; early-onset preeclampsia; gene expression; NT-proBNP; placenta; preeclampsia; trophoblasts; Obstetrik och gynekologi; Obstetrics and Gynaecology;

    Sammanfattning : Preeclampsia has several pathophysiological pathways, but the placenta has a central role. The pathophysiology appears to differ between the two subtypes – early- and late-onset preeclampsia. LÄS MER

  4. 4. Atrial natriuretic peptide in ischaemic acute renal failure

    Författare :Kristina Swärd; Göteborgs universitet; Göteborgs universitet; Gothenburg University; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES;

    Sammanfattning : .... LÄS MER

  5. 5. Early Risk Stratification, Treatment and Outcome in ST-elevation Myocardial Infarction

    Författare :Erik Björklund; Bertil Lindahl; Lars Wallentin; Ulf Näslund; Uppsala universitet; []
    Nyckelord :MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Medicine; Acute myocardial infarction; Thrombolysis; Troponin; Electrocardiography; Natriuretic peptide; Prognosis; Prehospital thrombolysis; Treatment delay; Mortality; Registry; Clinical trial; Medicin; Dermatology and venerology; clinical genetics; internal medicine; Dermatologi och venerologi; klinisk genetik; invärtesmedicin;

    Sammanfattning : We evaluated, in patients with ST-elevation myocardial infarction (STEMI) treated with thrombolytics, admission Troponin T (tnT), ST-segment resolution and admission N-terminal pro-brain natriuretic peptide (NT-proBNP) for early risk stratification as well as time delays and outcome in real life patients according to prehospital or in-hospital thrombolytic treatment. Also, baseline characteristics, treatments and outcome in patients enrolled in the ASSENT-2 trial in Sweden and in patients not enrolled were evaluated. LÄS MER